Literature DB >> 9055431

Protamine-induced permeabilization of cell envelopes of gram-positive and gram-negative bacteria.

C Johansen1, A Verheul, L Gram, T Gill, T Abee.   

Abstract

The inhibitory effect of the cationic peptide protamine on Listeria monocytogenes, Escherichia coli, and Shewanella putrefaciens has been studied in detail. The addition of protamine (10 to 1,000 micrograms/ml) resulted in inhibition of oxygen consumption after less than 1 min and loss of intracellular carboxyfluorescein and ATP after 2 to 5 min. Maximum antibacterial activity was reached at alkaline pH and in the absence of divalent cations. The efficient permeabilization of cell envelopes of both gram-positive and gram-negative bacteria suggests that protamine causes a general disruption of the cell envelope, leading to a rapid and nonspecific efflux of low- and high-molecular-weight compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9055431      PMCID: PMC168406          DOI: 10.1128/aem.63.3.1155-1159.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  19 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes.

Authors:  B L Kagan; M E Selsted; T Ganz; R I Lehrer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 3.  A novel role of Ca2+ and Zn2+: protection of cells against membrane damage.

Authors:  C A Pasternak
Journal:  Biosci Rep       Date:  1988-12       Impact factor: 3.840

4.  Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.

Authors:  B Christensen; J Fink; R B Merrifield; D Mauzerall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Transient accumulation of potassium glutamate and its replacement by trehalose during adaptation of growing cells of Escherichia coli K-12 to elevated sodium chloride concentrations.

Authors:  U Dinnbier; E Limpinsel; R Schmid; E P Bakker
Journal:  Arch Microbiol       Date:  1988       Impact factor: 2.552

6.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane.

Authors:  T Abee; T R Klaenhammer; L Letellier
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

8.  Effect of growth conditions on the fatty acid composition of Listeria monocytogenes and comparison with the fatty acids of Erysipelothrix and Corynebacterium.

Authors:  R A Tadayon; K K Carroll
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

9.  Effect of sodium chloride on the intracellular solute pools of Listeria monocytogenes.

Authors:  R A Patchett; A F Kelly; R G Kroll
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

10.  Growth and activity of Shewanella putrefaciens isolated from spoiling fish.

Authors:  B R Jørgensen; H H Huss
Journal:  Int J Food Microbiol       Date:  1989-08       Impact factor: 5.277

View more
  19 in total

1.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus.

Authors:  Madhuri Singh; Kasturi Mukhopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.

Authors:  Maria Pränting; Aurel Negrea; Mikael Rhen; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

4.  Inhibitory effects of protamines on proteolytic and adhesive activities of Porphyromonas gingivalis.

Authors:  M Kontani; A Amano; T Nakamura; I Nakagawa; S Kawabata; S Hamada
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.

Authors:  Wiebke Arendt; Stefanie Hebecker; Sonja Jäger; Manfred Nimtz; Jürgen Moser
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

6.  Antibacterial activity of licochalcone A against spore-forming bacteria.

Authors:  Ryo-Ichi Tsukiyama; Harumi Katsura; Nozomu Tokuriki; Makio Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  Characterization of two genes involved in chromate resistance in a Cr(VI)-hyper-resistant bacterium.

Authors:  Francesca Decorosi; Enrico Tatti; Annalisa Mini; Luciana Giovannetti; Carlo Viti
Journal:  Extremophiles       Date:  2009-09-19       Impact factor: 2.395

8.  Elucidation of the antibacterial mechanism of the Curvularia haloperoxidase system by DNA microarray profiling.

Authors:  Eva H Hansen; Mark A Schembri; Per Klemm; Thomas Schäfer; Søren Molin; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

9.  Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli.

Authors:  S Stumpe; R Schmid; D L Stephens; G Georgiou; E P Bakker
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

10.  SSD1 is integral to host defense peptide resistance in Candida albicans.

Authors:  Kimberly D Gank; Michael R Yeaman; Satoshi Kojima; Nannette Y Yount; Hyunsook Park; John E Edwards; Scott G Filler; Yue Fu
Journal:  Eukaryot Cell       Date:  2008-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.